Free Trial
NYSEAMERICAN:XTNT

Xtant Medical (XTNT) Stock Price, News & Analysis

Xtant Medical logo
$0.69 +0.04 (+5.84%)
As of 04:10 PM Eastern

About Xtant Medical Stock (NYSEAMERICAN:XTNT)

Key Stats

Today's Range
$0.65
$0.69
50-Day Range
$0.47
$0.74
52-Week Range
$0.33
$0.83
Volume
17,358 shs
Average Volume
122,472 shs
Market Capitalization
$95.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
Consensus Rating
Buy

Company Overview

Xtant Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

XTNT MarketRank™: 

Xtant Medical scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Xtant Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Xtant Medical has received no research coverage in the past 90 days.

  • Read more about Xtant Medical's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Xtant Medical is -7.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Xtant Medical is -7.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Xtant Medical has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Xtant Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.04% of the float of Xtant Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Xtant Medical has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Xtant Medical has recently increased by 133.47%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Xtant Medical does not currently pay a dividend.

  • Dividend Growth

    Xtant Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.04% of the float of Xtant Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Xtant Medical has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Xtant Medical has recently increased by 133.47%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Xtant Medical has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Xtant Medical this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Xtant Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.70% of the stock of Xtant Medical is held by insiders.

  • Percentage Held by Institutions

    69.33% of the stock of Xtant Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Xtant Medical's insider trading history.
Receive XTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter.

XTNT Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

XTNT Stock Analysis - Frequently Asked Questions

Xtant Medical's stock was trading at $0.4681 at the beginning of the year. Since then, XTNT stock has increased by 47.1% and is now trading at $0.6885.

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) announced its earnings results on Tuesday, November, 12th. The medical device company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.02. The medical device company had revenue of $27.94 million for the quarter. Xtant Medical had a negative net margin of 9.81% and a negative trailing twelve-month return on equity of 27.01%.
Read the conference call transcript
.

Shares of Xtant Medical reverse split on Wednesday, February 14th 2018.The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Xtant Medical investors own include Meta Platforms (META), Aurinia Pharmaceuticals (AUPH), NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA) and Broadcom (AVGO).

Company Calendar

Last Earnings
11/12/2024
Today
7/10/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:XTNT
Previous Symbol
AMEX:XTNT
CIK
1453593
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$1.50
Low Price Target
$1.50
Potential Upside/Downside
+117.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.45 million
Net Margins
-9.81%
Pretax Margin
-9.73%
Return on Equity
-27.01%
Return on Assets
-12.49%

Debt

Debt-to-Equity Ratio
0.51
Current Ratio
2.34
Quick Ratio
1.03

Sales & Book Value

Annual Sales
$117.27 million
Price / Sales
0.82
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.31 per share
Price / Book
2.22

Miscellaneous

Outstanding Shares
139,320,000
Free Float
125,809,000
Market Cap
$95.92 million
Optionable
Not Optionable
Beta
-0.14
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSEAMERICAN:XTNT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners